fig2
![Impact of previous anti-angiogenesis treatment in nivolumab-treated advanced non-small cell lung cancer](https://image.oaes.cc/016e0f3c-6277-443c-968c-559c51b68275/2353.fig.2.png)
Figure 2. Impact of previous anti-angiogenesis treatment on progression-free survival. A: Progression-free survival curves were plotted according to prior anti-angiogenesis treatment; B: Relationship between number of prior anti-angiogenesis doses and progression-free survival on nivolumab